OXTR and pulmonary arterial hypertension: Recent studies have shown that low-dose oxytocin is as effective as high-dose oxytocin in the first-line setting for PPH prevention.[17] It is known that at high doses, the oxytocin receptor undergoes desensitization with agonist exposure.[17] Therefore, secondary uterotonics should be considered earlier.